$AUXL Recent Headlines Auxilium shares soar after FDA

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$AUXL Recent Headlines

Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - Russ Britt
Charting a slow-motion ‘break’ atop Nasdaq 4,000 12:34 p.m. Nov. 26, 2013 - Michael Ashbaugh
Charting a slow-motion ‘break’ atop Nasdaq 4,000 12:19 p.m. Nov. 26, 2013 - Michael Ashbaugh
Earnings, deals aid medical supplier, biopharmas on mixed market day 10:32 a.m. Oct. 11, 2013 - Russ Britt
Charting the S&P 500’s next technical target 10:47 a.m. July 19, 2013 - Michael Ashbaugh
Auxilium posts first quarterly profit; revenue up 9:20 a.m. July 31, 2012 - MarketWatch.com
U.S. benchmarks face technical hurdles 11:17 a.m. June 12, 2012 - Michael Ashbaugh
U.S. benchmarks face technical hurdles 10:49 a.m. June 12, 2012 - Michael Ashbaugh
S&P 500 balks at resistance 10:37 a.m. June 8, 2012 - Michael Ashbaugh
Monday’s biggest gaining and declining stocks 1:40 p.m. June 4, 2012 - MarketWatch
Auxilium shares rally on late-stage trial results 8:40 a.m. June 4, 2012 - MarketWatch.com
Nasdaq rises to the breakdown point 10:47 a.m. Dec. 16, 2011 - Michael Ashbaugh
Monday’s biggest gaining and declining stocks 4:17 p.m. Oct. 31, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 3:36 p.m. Aug. 1, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:40 p.m. Jan. 10, 2011 - Kate Gibson
Auxilium rallies; drug indexes dip 4:36 p.m. Jan. 10, 2011 - Val Brickates Kennedy
Auxilium rallies as drug indexes slide 10:04 a.m. Jan. 10, 2011 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:38 p.m. July 12, 2010 - MarketWatch
Market bulls defend the March peak 10:05 a.m. April 29, 2010 - Michael Ashbaugh
Wednesday's biggest gaining and declining stocks 4:19 p.m. Dec. 16, 2009 - MarketWatch


Jefferies hikes target on Auxilium citing PD potential 10:06 a.m. Today - Seeking Alpha
FDA Approves First Peyronie's Disease Drug Treatment 4:01 p.m. Dec. 6, 2013 - WSJ.com
Mid-Afternoon Market Update: Markets Gain on Jobs Number; InterOil Falls on Sale of Major Asset 3:00 p.m. Dec. 6, 2013 - benzinga.com
Auxilium Xiaflex Drug Wins New Label, Stock Jumps 1:27 p.m. Dec. 6, 2013 - Investors Business Daily
Auxilium Pharmaceuticals (AUXL) Marked As A Barbarian At The Gate 12:53 p.m. Dec. 6, 2013 - TheStreet.com
Today's Dead Cat Bounce Stock Is Auxilium Pharmaceuticals (AUXL) 10:00 a.m. Dec. 5, 2013 - TheStreet.com
Summer Street out with bearish commentary on Auxilium 9:29 a.m. Dec. 5, 2013 - Seeking Alpha
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Auxilium: Serious Red Flags Make The Upcoming FDA Decision For Xiaflex A 'High Risk' 11:40 a.m. Dec. 2, 2013 - Seeking Alpha
Label Expansion for Roche's Avastin in Japan - Analyst Blog 11:40 a.m. Nov. 27, 2013 - Zacks.com
Novartis to Buy Back Shares - Analyst Blog 6:00 p.m. Nov. 25, 2013 - Zacks.com
4 Biotech Stocks With Upcoming FDA Decision Dates 9:14 a.m. Nov. 25, 2013 - Seeking Alpha
Auxilium Presented New Analyses of XIAFLEX Peyronie's Disease Data at SMSNA Meeting 6:01 a.m. Nov. 25, 2013 - benzinga.com
Data on Auxilium Pharma's Xiaflex - Analyst Blog 12:10 p.m. Nov. 22, 2013 - Zacks.com
Cadence Wins Lawsuit, Shares Up - Analyst Blog 6:02 p.m. Nov. 21, 2013 - Zacks.com
New Research And Competition Could Hurt AbbVie's Other Blockbuster 12:21 p.m. Nov. 21, 2013 - Seeking Alpha
First Week Of AUXL January 2014 Options Trading 11:55 a.m. Nov. 19, 2013 - TheStreet.com
Auxilium Announces Results Of The XIAFLEX In Dupuytren's MULTICORD Contracture Phase 3b Trial 6:05 a.m. Nov. 18, 2013 - benzinga.com
Auxilium Pharmaceuticals, Inc. (AUXL) Shares March Higher, Can it Continue? - Tale of the Tape 8:53 a.m. Nov. 14, 2013 - Zacks.com


Strategic Collaborations, Clinical Studies, Regulatory Update, and Other Corporate Announcements - Research Report on OncoMed, Auxilium Pharma, BioTelemetry, Progenics Pharma, and Ambit Biosciences 8:00 a.m. Today - PR Newswire
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX® for the Treatment of Peyronie's Disease 1:29 p.m. Dec. 6, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. To Present At The Oppenheimer Conference 4:34 p.m. Dec. 5, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Court Grants Upsher-Smith Laboratories Motion For Summary Judgment 5:05 p.m. Dec. 4, 2013 - PR Newswire
Healthcare Sector Announces Acquisitions and Innovations - Research Report on Synta, Auxilium Pharmaceuticals, Accuray, and USANA 8:00 a.m. Nov. 29, 2013 - PR Newswire
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX® Peyronie's Disease Data at SMSNA Scientific Meeting 7:00 a.m. Nov. 25, 2013 - PR Newswire
Investments on New Facilities, Marketing Grants, Commercial Releases, and Trial Results - Research Report on AstraZeneca, Theravance, Accuray, Volcano, and Auxilium 8:00 a.m. Nov. 21, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. to Present Data on XIAFLEX® at the Fall Scientific Meeting of the Sexual Medicine Society of North America 7:00 a.m. Nov. 20, 2013 - PR Newswire
Auxilium Announces Results Of The XIAFLEX® In Dupuytren's MULTICORD Contracture Trial 7:00 a.m. Nov. 18, 2013 - PR Newswire
Healthcare Companies Report Financial Results, Scheduled Presentations, Marketing Clearance and Recognitions - Research Report on Air Methods, NeuroMetrix, Quintiles, Auxilium, and Cynosure 8:00 a.m. Nov. 12, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results 7:00 a.m. Nov. 6, 2013 - PR Newswire
Healthcare Sector Announced Financial Results - Research Report on Ligand, Auxilium, STERIS, USANA, and Cardiovascular Systems 8:00 a.m. Nov. 4, 2013 - PR Newswire
Arbitration Awards, Shareholder Meetings, Marketing Agreements, New Appointments and Upcoming Earnings Schedules - Research Report on Valeant, Perrigo, IDEXX, Auxilium, and PerkinElmer 9:00 a.m. Oct. 30, 2013 - PR Newswire
Auxilium Pharmaceuticals to Announce Third Quarter 2013 Results on November 6, 2013 9:00 a.m. Oct. 24, 2013 - PR Newswire
BioSpecifics Technologies Corp. Announces Initiation of Phase 2a Study of XIAFLEX for Treatment of Cellulite 9:35 a.m. Oct. 23, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2a Cellulite Study of Collegenase Clostridium Histolyticum 8:00 a.m. Oct. 23, 2013 - PR Newswire
VIVUS, Inc. Announces License Agreement for the Marketing Rights to STENDRA in the United States and Canada 7:00 a.m. Oct. 11, 2013 - GlobeNewswire
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada 7:00 a.m. Oct. 11, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 8:00 a.m. Oct. 9, 2013 - PR Newswire
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX® For The Treatment Of Dupuytren's Contracture 7:30 a.m. Oct. 7, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Updated Category News Views 2

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Continue Reading
Jixingfeng Advances Smart Manufacturing for Socks Market

Updated Category News Views 3

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Continue Reading
Multiconsult-Rejlers Merger Revs Up Nordic Market Power

Updated Category News Views 2

A New Powerhouse in the Nordic Consultancy Space September 7, 2026, will likely be etched into the annals of stock market moves, marking the day two titans, Multiconsult and Rejlers, decided to tie the knot. This isn't your average merger. We're talking about a calculated Pan-Nordic push that's been building, and now, well, it's paying off with a potential powerhouse of...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 1

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Snack Bars Market to Hit $32.66B by 2031: Growth and Challenges

Updated Category News Views 2

Snack Bars Navigate a Transforming Market There's a headwind in the snack bars market as it looks to lift off from $21.94 billion and land at $32.66 billion by 2031. That's a solid climb at an 8.28% CAGR. What's fueling this leap? A desire for convenient, portable nutrition that's squeezing into every nook of modern life—from the gym to the car, to your kid's lunchbox....

Continue Reading
EQT Wraps Up Share Buyback with 4.3M Shares Repurchased

Updated Category News Views 1

EQT's Bold Buyback: Crunching the Numbers Alright, let's peel back the curtain on EQT's latest maneuver—finishing up their share buyback program, all neat and tidy for 2026. They nailed down 707,203 of their own shares just in the first week of September, part of a grand total of 4,368,899 snatched up in the entire effort. That's a whopping SEK 1.448 billion invested in...

Continue Reading
Cultural Convergence: Ordos Event Captivates Global Visitors

Updated Category News Views 1

Ordos: Where Cultures Connect Seamlessly Spanning continents and cultures, the recent 'Warm City' event in Ordos, Inner Mongolia, drew international attention like bees to honey. Now, if you're thinking this is just another cultural shindig, think again. François Tchiegue, an ambassador of China-Africa cultural exchanges, described it best when he noted how the morin...

Continue Reading
Insurance 101: Know Your Limits and Deductibles

Updated Category News Views 4

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

Continue Reading
AB SKF to Hold EGM, Spin Off Automotive Assets

Updated Category News Views 3

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Continue Reading
Kean-NJCU Merger: A Strategic Educational Move

Updated Category News Views 3

The clock's ticked for Kean University and New Jersey City University, landing them into a fusion that's set tongues wagging across the education sector. This ain't just another day at the park—it’s a significant shift in the academic landscape that deserves a closer, sharper look. Behind the Curtains of Strategic Planning So, who’s behind the wheel charting this...

Continue Reading

Top 5 Most Recently Viewed Articles

Berkshire Hathaway's Bold Moves with Apple and Alphabet Stocks

Updated Category News Views 325

Warren Buffett's Strategic Moves as He Approaches Retirement Warren Buffett’s Berkshire Hathaway (NYSE: BRKb) has recently unveiled its much-anticipated Q3 13F filing, highlighting significant alterations within its investment portfolio during the quarter. As Buffett prepares for retirement at the end of 2025, he leaves Berkshire with a remarkable amount of cash, but...

Continue Reading
Understanding the ASML Holding N.V. Class Action Lawsuit

Updated Category News Views 331

ASML Holding N.V. Class Action Updates The Gross Law Firm has issued an important notice to shareholders of ASML Holding N.V. (NASDAQ: ASML), emphasizing the significance of a pending class action lawsuit. This notice brings attention to the timeline for shareholders who purchased shares of ASML, as they may have the opportunity to engage in this legal process. The firm...

Continue Reading
Techint Labs Launches Innovative Website for Future Growth

Updated Category News Views 238

Techint Labs Launches Innovative Website for Future Growth Techint Labs is a full-service advertising agency that designs custom strategies to accelerate brands. This forward-thinking agency is thrilled to share an exciting development with its clients and partners: the launch of its newly redesigned website. A New Digital Era for Techint Labs In a significant step...

Continue Reading
How $100 in Fluor Became Nearly $300 Over Five Years

Updated Category News Views 142

Transforming $100 Investment in Fluor Fluor (NYSE: FLR) has exhibited remarkable performance over the last five years, surpassing market expectations with an average annual return of 24.8%. In the financial landscape, this impressive record has translated into a 11.55% annualized outperformance. With a market capitalization standing at $6.83 billion, the company has...

Continue Reading
WuXi Biologics Nails AAA ESG Rating, Fourth Year Running

Updated Category News Views 5

A Nod to Consistent ESG Excellence When a company keeps hitting a high note like WuXi Biologics (2269.HK), world markets take notice. Let me tell you, getting the MSCI's AAA ESG rating four years in a row isn't just a feather in the cap; it's a whole damn peacock of credibility in the cut-throat arena of global biopharma. This ain't just another corporate pat on the...

Continue Reading